Sam Lovick Consulting presented the following at the 7th International Conference on Infectious Disease Dynamics in December 2019. It addresses the health benefits that could arise in the US from a vaccine available at pandemic onset which is not precisely matched to the circulating strain. The modelled vaccine is sufficiently closely matched to provide some level, albeit a lower level, of protection against infection.